U.K. study strengthens case for breast MR screening

Article

A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.

A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.

The investigators found MRI significantly more sensitive than mammography (77% versus 40%) in detecting breast cancers across the group of 649 women. Combining the results increased the sensitivity to 94%. MRI proved especially effective in BRCA1 mutation carriers, in whom it detected all tumors. Both techniques were needed to spot all cancers in women carrying BRCA2 mutations.

Commenting on the study, Dr. Ellen Warner, a medical oncologist at Toronto-Sunnybrook Regional Cancer Centre, said that mammography may one day be abandoned for high-risk women.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.